The latest financial statement is for the year ending 2025-12-31.
| Cash Flow | 2025-12-31 |
|---|---|
| Depreciation and amortization | 655 |
| Provision for inventory obsolescence | 341 |
| Provision for product warranties | 214 |
| Loss on disposal of property and equipment | -19 |
| Stock based compensation | 2,001 |
| Allowance for credit losses | 423 |
| Non-cash lease expense | 86 |
| Non-cash interest expense | 956 |
| Trade receivables | 1,318 |
| Prepaid expenses and other assets | -237 |
| Inventories | 1,074 |
| Accounts payable | 355 |
| Accrued and other liabilities | 209 |
| Net loss | -11,105 |
| Net Cash Provided By Used In Operating Activities | -8,001 |
| Net change in cash and cash equivalents | -1 |
| Cash and cash equivalents, beginning of year | 31,741 |
| Cash and cash equivalents, end of year | 31,740 |
Apyx Medical Corp (APYX)
Apyx Medical Corp (APYX)